Cancer of Unknown Primary Clinical Trials

8 clinical trials for Cancer of Unknown Primary across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Agnostic Therapy in Rare Solid Tumors — RECRUITING · PHASE2
• Enabling Genomic Testing in Cancer of Unknown Primary — RECRUITING
• [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin — RECRUITING · NA
• Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary — NOT_YET_RECRUITING · PHASE2
• Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary — NOT_YET_RECRUITING · PHASE2
• Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors — COMPLETED · PHASE1
• PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP — OTHER · PHASE2
• Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary — OTHER · PHASE2

Refine this search